Since 2000, more than 200 contract research organizations (CROs) providing services to global pharmaceutical and biotech companies have been founded in China, most of which are founded by scientists and businessmen trained in US, Europe, and Japan. It is not a surprise because you can easily meet Chinese students and scholars in almost all laboratires in the US and Europe universities and institutes. In the past three decades, tens of thousands of Chinese students and scholars have been trained in US, Europe and Japan. Most of them are biologiests and Chemists. Because Chinese are smart and hard-working, in almost each issue of top scientific journals such as Nature, Science, and Cell, there are Chinese co-authors. Since 1990s, more and more Chinese scientists have been back to China to work in Academy and later industry for short or long terms. 

Established in December 2000, WuXi AppTec is a leading global pharmaceutical, biopharmaceutical and medical device outsourcing company with operations in China and the United States.  As a research-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of laboratory and manufacturing services across the discovery-to-commercialization spectrum. Its services are designed to assist customers worldwide in shortening the time and lowering the cost of drug and medical device R&D by providing cost-effective and efficient outsourcing solutions.

Founded in 2003, Shanghai ChemPartner Co. Ltd. (ChemPartner) has become one of the leading contract research organizations (CROs) providing chemistry, biology, pharmacology, DMPK, process R&D, pre-formulation and analytical development services to global pharmaceutical and biotech companies. With its strength in a full spectrum of chemistry, DMPK and biology services, ChemPartner is uniquely positioned to support its customers in fully integrated programs that expedite drug discovery and development processes at lower costs. ChemPartner can perform target validation, assay development, HTS, hit-to-lead optimization and pre-clinical candidate delivery.  

BioDuro is a leading biotech services company that is focused on creating high-quality, integrated R&D capabilities to meet the growing needs of the global biotechnology and pharmaceutical industries. By combining its breadth of internationally experienced medicinal chemists and discovery biologists with a PhD ratio of 1:3 on integrated programs. BioDuro has experience running successful, fully-integrated, hit-to-lead programs for major pharmaceutical companies and small biotechs. For these projects, BioDuro is providing parallel synthesis of compound sets, iterative medicinal chemistry, biochemistry, physicochemical assays, cell biology, in vivo biology and DMPK services. Most importantly it has the knowledge required to integrate all of these scientific functions into a team that can deliver compounds into the clinic.

Founded in 2003 and managed by a team with extensive experience in drug discovery and development in US pharmaceutical and biotech companies, Medicilon offers integrated pharmaceutical services designed to further your drug discovery and development efforts. Its services include but are not limited to custom chemical synthesis, pharmacokinetics, metabolism, bioanalytical, structural biology service, pharmacology, and animal models. 

As one of the top contract research organizations in the field of life science services, GenScript has created a one-stop, customizable service package that incorporates custom gene synthesis & cloning, peptide synthesis, protein production & purification, monoclonal & polyclonal antibody production, and siRNA & miRNA services. GenScript provides direct support by acting as the client’s R&D bio-reagent center and bio-assay center.

Tigermed Consulting Ltd. specializes in pharmaceutical research and development. It offers a broad range of services including all phases of clinical studies, registration (chemical and biological drugs, medical device and functional food etc.), new drug development and technology transfer, GCP training, marketing research and so on.

Founded by a group of veterans from US biopharmaceutical industries in 2004, Sundia MediTech Company Ltd. is now a leading Shanghai-based pharmaceutical and biotech R&D out-sourcing company. Recently merged with United PharmaTech and formed alliance with HD Biosciences, Sundia offers broad and integrated services of custom organic synthesis, medicinal chemistry, process chemistry, APIs manufacturing under cGMP or non-cGMP, bioassay, and in vitro & in vivo PK studies. Sundia has successfully established collaborations with over 60 client companies in North America, Europe, and Japan.

You can find more contract research companies from the worldwide on Ushelf.com.